Vericel Corporation (VCEL) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Vericel Corporation (VCEL) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

VCEL

Market Closed

Vericel Corporation

NASDAQHealthcare Biotechnology

357 employees

CEO: Dominick C. Colangelo

Founded: 1997

$37.46

+$0.00(+NaN%)

Market Cap

1.91B

Beta

1.13

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

74.4%

19.5%

CAGR: 18.0%

Profit after direct costs

Operating Margin

4.0%

144.4%

CAGR: N/A

Core business profitability

Net Margin

6.0%

59.4%

CAGR: N/A

Bottom line profitability

Revenue Growth

16.5%

YoY

CAGR: 15.3%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how VCEL allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

74.4%

$205.60M

Operating Margin

4.0%

$11.04M

Net Margin

6.0%

$16.52M

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	156.18M	164.37M	197.52M	237.22M	276.26M	16.5%
Cost of Revenue	(50.16M)	(54.58M)	(61.94M)	(65.12M)	(70.66M)	8.5%
Gross Profit	106.03M	109.79M	135.58M	172.11M	205.60M	19.5%
Operating Expenses
Research & Development	(16.29M)	(19.94M)	(21.04M)	(24.80M)	(27.56M)	11.2%
Selling, General & Administrative	(97.59M)	(106.90M)	(121.00M)	(142.79M)	(166.99M)	16.9%
Depreciation & Amortization	(2.96M)	(3.98M)	(4.63M)	(5.50M)	(11.36M)	106.4%
Operating Income (EBIT)	-7.85M	-17.06M	-6.46M	4.52M	11.04M	144.4%
Non-Operating Items
Interest Income	224.00K	1.34M	4.63M	6.41M	7.01M	9.3%
Interest Expense	(4.00K)	(366.00K)	(600.00K)	(614.00K)	(1.56M)	153.4%
Other Income/Expenses (Net)	272.00K	1.07M	4.10M	5.99M	6.33M	5.7%
Income Before Tax	-7.58M	-15.99M	-2.37M	10.51M	17.38M	65.3%
Income Tax Expense	(111.00K)	(721.00K)	(814.00K)	(148.00K)	(859.00K)	480.4%
Net Income	-7.47M	-16.71M	-3.18M	10.36M	16.52M	59.4%
Per Share Metrics
Earnings Per Share (Basic)	$-0	$-0	$-0	$0	$0	57.1%
Weighted Avg Shares Outstanding	46.47M	47.13M	47.59M	48.85M	50.59M	3.6%
Weighted Avg Shares Outstanding (Diluted)	46.47M	47.13M	47.59M	51.68M	52.07M	0.8%
EBITDA	-4.61M	-11.64M	2.86M	16.63M	30.29M	82.2%

Explore VCEL

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

VCEL in the Healthcare

Small Cap

Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →